These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2. Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420 [TBL] [Abstract][Full Text] [Related]
5. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937 [TBL] [Abstract][Full Text] [Related]
6. Cotransplantation with myeloid-derived suppressor cells protects cell transplants: a crucial role of inducible nitric oxide synthase. Arakawa Y; Qin J; Chou HS; Bhatt S; Wang L; Stuehr D; Ghosh A; Fung JJ; Lu L; Qian S Transplantation; 2014 Apr; 97(7):740-7. PubMed ID: 24642686 [TBL] [Abstract][Full Text] [Related]
7. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862 [TBL] [Abstract][Full Text] [Related]
8. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma. Xu Y; Fang F; Jiao H; Zheng X; Huang L; Yi X; Zhao W Cancer Immunol Immunother; 2019 Dec; 68(12):1959-1969. PubMed ID: 31641797 [TBL] [Abstract][Full Text] [Related]
9. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury. Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137 [TBL] [Abstract][Full Text] [Related]
10. Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice. Hanazawa A; Ito R; Katano I; Kawai K; Goto M; Suemizu H; Kawakami Y; Ito M; Takahashi T Front Immunol; 2018; 9():152. PubMed ID: 29456539 [TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism. Zhao Y; Shen XF; Cao K; Ding J; Kang X; Guan WX; Ding YT; Liu BR; Du JF Front Immunol; 2018; 9():282. PubMed ID: 29497426 [TBL] [Abstract][Full Text] [Related]
12. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models. Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449 [TBL] [Abstract][Full Text] [Related]
14. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway. Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418 [TBL] [Abstract][Full Text] [Related]
15. Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer. Xu M; Zhao Z; Song J; Lan X; Lu S; Chen M; Wang Z; Chen W; Fan X; Wu F; Chen L; Tu J; Ji J Exp Cell Res; 2017 Feb; 351(2):142-149. PubMed ID: 28109867 [TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells in Fresno M; Gironès N Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737 [TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. Wang Y; Schafer CC; Hough KP; Tousif S; Duncan SR; Kearney JF; Ponnazhagan S; Hsu HC; Deshane JS J Immunol; 2018 Jul; 201(1):278-295. PubMed ID: 29752311 [TBL] [Abstract][Full Text] [Related]
18. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188 [TBL] [Abstract][Full Text] [Related]
19. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice. Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053 [TBL] [Abstract][Full Text] [Related]
20. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma. Pang X; Fan HY; Tang YL; Wang SS; Cao MX; Wang HF; Dai LL; Wang K; Yu XH; Wu JB; Tang YJ; Liang XH PLoS One; 2020; 15(2):e0229089. PubMed ID: 32092078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]